Opendata, web and dolomites

MImETIC INDiRECT SIGNED

MIcrovascularizED Tumour-on-chip for Cellular ImagiNg of Drug Response and Cell moTility

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MImETIC INDiRECT project word cloud

Explore the words cloud of the MImETIC INDiRECT project. It provides you a very rough idea of what is the project "MImETIC INDiRECT" about.

scientific    collaborations    flow    standardised    collaborative    designed    worldwide    microvascularized    acquisition    adoption    cherry    market    disruptive    microscopy    free    culture    toolkit    animal    confocal    clinical    academic    marketing    academia    chamber    standardization    unconventional    sensor    tissue    complementary    dictated    chip    direct    create    microfluidic    discovery    24    cellular    biology    collagenous    platforms    platform    consist    chips    cancerous    sectors    biotech    multidisciplinary    migration    compact    optional    industry    live    single    promotes    reproducible    model    personalized    cancer    envision    mimetic    components    plates    mitigation    sub    solutions    formulations    techniques    compatible    3d    lanes    manner    drug    skills    temperature    standardized    mentioned    risks    disseminated    collagen    biomimetic    o2    indirect    dual    toxicology    strategies    controller    accessible    optimized    medicine    lines    imaging    cell    appropriate    types    diverse    aforementioned    cubix    organ    commercial    versatile    integration   

Project "MImETIC INDiRECT" data sheet

The following table provides information about the project.

Coordinator
CHERRY BIOTECH 

Organization address
address: 6 RUE GURVAND
city: RENNES
postcode: 35000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 196˙707 €
 EC max contribution 196˙707 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2021-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CHERRY BIOTECH FR (RENNES) coordinator 196˙707.00

Map

 Project objective

MImETIC INDiRECT aims to develop a standardised, accessible, versatile organ-on-chip toolkit for cancer biology and drug discovery research, compatible with microscopy-based (live imaging and confocal) techniques. The project is expected to facilitate academia and industry adoption of microfluidic 3D cell culture systems for comparable and reproducible results in a complex biomimetic animal free model for cancer drug discovery, toxicology, advanced (pre)clinical as well as personalized medicine. The toolkit components will consist of an integrated temperature controller dual-chamber chip, the Cherry Biotech CubiX system and growth factor optimized collagenous solutions for each chip chamber. The dual chamber chip, with cellular migration lanes, will have two tailored collagen-based formulations, designed per chamber. The CubiX platform is a compact flow and temperature controller, allowing optional sensor (e.g. O2) integration, compatible with single chips or 24-well plates. The cancer(s) sub-types to be used toolkit standardization will be dictated by market needs, where commercial cell lines (cancerous and non-cancerous) will be used to create the microvascularized complex tissue model. Potential project risks have been identified with appropriate mitigation strategies, where the project promotes adoption of standardized, cost-effective and versatile cancer organ-on-chip platforms in the market, rather than disruptive academic findings. Access of the aforementioned system to a worldwide growth market will fully exploit the project results, disseminated by direct and indirect marketing and scientific approaches. Project implementation will be an academic-industry collaborative and multidisciplinary manner providing the acquisition of diverse and unconventional complementary skills, leading to an understanding of both sectors requirements. We envision the above-mentioned to facilitate future academic and industry collaborations.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MIMETIC INDIRECT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MIMETIC INDIRECT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

PERCEPSION (2020)

Sexual selection in plants: testing new ideas on the perception of the mating environment and on the mate choice physiology

Read More  

inTECH (2019)

Eco-innovative technologies for sustainable exploitation of macromolecules from insects as alternative resource in bioeconomy

Read More  

CO2RR VALCAT (2019)

Valence Band Tuning of Electrocatalysts for the CO2 Reduction Reaction

Read More